DJ HUGIN NEWS/Patient recruitment in Biofrontera's phase II study in severe chronic urticaria completed Corporate news announcement processed and transmitted by Hugin AS.
43492
Dj Hugin news/patient recruitment in Biofrontera's phase II study in severe chronic urticaria completed
55572
XenoPort announces positive results of a Phase 1 clinical trial of XP21279
98524
An oral agent for the treatment of moderate to severe psoriasis would earn a higher patient share in the United States than in Europe
78946
Protagonize.com is accepting submissions
105963
Lancaster Laboratories collaborates with BioAzure
78801
The Patient Recruiting Agency announces acne research study
1365
New drug strategy master plan being crafted --
172167
Roche discloses the results of first phase III clinical study using taspoglutide
75564
Pfizer pays out to doctors, researchers
127736
Bio-Rad coordinates proteomics initiative
91464
Prostate basal cell can spawn tumors in prostate gland:
93858
Novartis receives approval in the European Union for Menveo®, first quadrivalent conjugate vaccine in the
66662
Syntopix says receives positive results from Phase II cosmetic study
57885
Symposium on targeted cancer therapy, Heidelberg, Germany
124569
BioAlliance Pharma announces the
134688
Avesthagen scouting for partners for bioactive ingredients
81434
Company develops genetic test for scoliosis